This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.

Released: July 12, 2026·Last reviewed: October 15, 2026·Methodology v4.1

Researched By

Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

BPC-157: evidence, legality and safety

Quick answer

FDA status, read October 15, 2026BPC-157: Withdrawn from Category 2; not Category 1; not on the 503A list. FDA’s Category 2 page (current as of April 22, 2026) moves BPC-157 to “nominated but withdrawn” and still records its safety concerns: possible immunogenicity and peptide-impurity problems. FDA staff proposed not adding it to the 503A bulks list; the July 23, 2026 advisory committee reportedly voted 8–6 with one abstention to recommend it, for ulcerative colitis. What the July vote did and did not change → Sources: FDA Category 2 page · 503A category lists (May 14, 2026). What FDA’s 2026 warning letters to “research peptide” sellers say →

BPC-157 is a synthetic peptide marketed for tissue repair and gut health. It is NOT FDA-approved for any use, is not an approved drug or dietary supplement, and the FDA has moved to restrict its compounding. Nearly all supporting evidence comes from animal and laboratory studies; rigorous human clinical trials are lacking.

Regulatory statusNot FDA-approved. Not a dietary supplement. Human clinical evidence is minimal.

What does the evidence actually show?

What human clinical evidence exists?

There are essentially no adequate, well-controlled human trials establishing efficacy or safety.

What do the animal and laboratory studies show?

Rodent studies suggest effects on tendon, muscle and gut-tissue healing. Animal findings do not reliably predict human results. We keep animal and laboratory findings clearly separated from human evidence, because preclinical results routinely fail to translate to people.

What are the known and potential risks?

Because the compound is unapproved and largely produced outside regulated pharmaceutical supply chains, purity, dose accuracy and contamination are real concerns.

No consumer dosing for research compoundsThis page does not provide dosing instructions for unapproved compounds, and we do not link to research-chemical sellers. If you are considering peptide therapy, do it through a licensed clinician who can weigh your individual risks.

Is it legal, and where does it come from?

The lawful pathway for any prescription peptide is a licensed clinician and a licensed pharmacy. Products labeled "for research use only" are not lawfully sold for human consumption. See how to verify a peptide provider and research peptides versus prescription therapy.

Is it banned in sport?

Prohibited status under anti-doping codes should be assumed; athletes must check the current WADA Prohibited List.

Frequently asked questions

Is BPC-157 legal to compound in 2026?

As of October 15, 2026, BPC-157 cannot be compounded within FDA's section 503A framework, because it is not on FDA's 503A bulks list, is not in Category 1 and is not an approved drug, and FDA's Category 2 page now lists it as nominated but withdrawn. An FDA advisory committee reportedly voted 8–6, with one abstention, in July 2026 to recommend adding it for ulcerative colitis, against FDA staff advice. The vote is non-binding and no rule had been proposed by October 15. Products labelled "research use only" are not a lawful route to human use.

Is BPC-157 FDA-approved?

Not FDA-approved. Not a dietary supplement. Human clinical evidence is minimal.

Is there human evidence for BPC-157?

There are essentially no adequate, well-controlled human trials establishing efficacy or safety.

Is BPC-157 legal to buy?

Many peptides in this category are sold as 'research chemicals,' which is not a lawful pathway for human use. Legitimacy depends on approval status and whether a licensed clinician and pharmacy are involved. We do not link to research-chemical sellers.

Is BPC-157 banned in sport?

Prohibited status under anti-doping codes should be assumed; athletes must check the current WADA Prohibited List.

Sources

U.S. Food and Drug Administration — enforcement actions and warnings on unapproved peptide products.
World Anti-Doping Agency (WADA) Prohibited List — current edition.
Peer-reviewed preclinical and (where available) clinical literature, graded for evidence quality.

Spotted an error? Submit a correction.

How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.